Journal of pharmacy & bioallied sciences · 2023
Efficacy of Oral Colchicine and Intralesional Hyaluronidase with and without Ultrasound Therapy in the Management of Oral Submucous Fibrosis-A Comparative Study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shil Malabika, Goswami Poulami, Gaikwad Trupti Vijay, Jadaun Gargi, Sridhar T, Bandyopadhyay Basudhara, Surana Pratik
Аннотация
AIM: To determine the therapeutic effect and efficacy of oral colchicine tablet and intralesional injection of hyaluronidase with and without ultrasound therapy in the clinical course of oral submucous fibrosis.
MATERIALS AND METHODS: This comparative study involving 45 human participants was divided into three equal groups. The participants in group 1 received oral colchicine and intralesional hyaluronidase. The participants in group 2 received oral colchicine, intralesional hyaluronidase, and ultrasound therapy. The group 3 participants were treated with intralesional dexamethasone and hyaluronidase. Intergroup assessments were done using repeated measures of ANOVA test, where P value of <0.05 was considered as statistically significant difference.
RESULTS: Group 2 patients had maximum improvement with respect to all the parameters.
CONCLUSION: Therapeutic ultrasound can be given effectively as an adjunct therapy along with conventional therapy in OSMF patients.
MATERIALS AND METHODS: This comparative study involving 45 human participants was divided into three equal groups. The participants in group 1 received oral colchicine and intralesional hyaluronidase. The participants in group 2 received oral colchicine, intralesional hyaluronidase, and ultrasound therapy. The group 3 participants were treated with intralesional dexamethasone and hyaluronidase. Intergroup assessments were done using repeated measures of ANOVA test, where P value of <0.05 was considered as statistically significant difference.
RESULTS: Group 2 patients had maximum improvement with respect to all the parameters.
CONCLUSION: Therapeutic ultrasound can be given effectively as an adjunct therapy along with conventional therapy in OSMF patients.